ArticlePatterns (New York, N.Y.)2026
DestinyNet: A deep-learning framework for cell-fate analysis from lineage-tracing single-cell RNA sequencing data.
Article in Patterns (New York, N.Y.), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Computational approaches for multimodal lineage tracing.Nature reviews. Genetics · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Unraveling cell-development dynamics, including lineage commitment, differentiation, and disease progression, is fundamental to biology. Despite advances in single-cell omics and barcoding technologies, comprehensive frameworks for accurate, robust, and scalable cell-fate analysis using lineage-tracing single-cell RNA sequencing (LT-scSeq) data remain limited. We introduce DestinyNet, a multi-task deep-learning framework addressing three key challenges: (1) fate clustering, integrating fate and cell-type information; (2) fate flow, depicting dynamic pseudotime trajectories with fate information; and (3) fate prediction, identifying early-stage cell-fate biases. DestinyNet enables end-to-end cell representation learning through cell-relation triplets and is robust across various LT-scSeq data types, including static, cumulative, and dynamic barcoding with single or multiple time points. Experiments on diverse datasets, including hematopoiesis differentiation and fibroblast reprogramming (
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.